Remove Gene Remove Gene Therapy Remove Genetic Analysis
article thumbnail

What Do Patients Have to Say about Gene Therapy Trials? An Upcoming FDA Public Meeting to Hear from Patients and Caregivers

FDA Law Blog

This meeting will host a panel of rare disease patients, caregivers, and advocates to have a focused discussion on the emerging field of gene therapy (regulated at the FDA by OTP). At least some (if not all) of the panelists will have had experience participating in gene therapy trials.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

While these therapies span all stages of clinical development, they are particularly concentrated in earlier phases, indicating strong future growth. RNA-based therapies hold the potential to offer new treatment options for diseases with limited or inadequate therapeutic alternatives. billion in 2021, is projected to reach $42.56